In summary, we show that Per2, which had a negative correlation with WHO grade in glioma samples, had a valuable prognosis and better survival from the CGGA and TCGA databases, while Id3, which had a positive correlation with WHO grade in glioma samples, had a poor prognosis and worse survival from the datasets. This evidence concerns the gene ID3 and central nervous system cancer.